Provided by Tiger Trade Technology Pte. Ltd.

ProShares Pet Care ETF

52.16
0.0000
Volume:55
Turnover:2.86K
Market Cap:33.90M
PE:- -
High:52.16
Open:52.16
Low:52.16
Close:52.16
52wk High:58.24
52wk Low:45.96
Shares:650.00K
Float Shares:650.00K
Volume Ratio:0.04
T/O Rate:0.01%
Dividend:0.35
Dividend Rate:0.67%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Merck & Co Inc Stock (MRK) Moved Up by 3.76% on Aug 25: A Full Analysis

TradingKey
·
Aug 26

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
Aug 26

Merck Price Target Raised to $170.00/Share from $145.00 by Argus Research

Dow Jones
·
Aug 25

Merck & Company (MRK) Gets a Buy from Scotiabank

TIPRANKS
·
Aug 25

Merck price target raised to $170 from $145 at Argus

TIPRANKS
·
Aug 25

Merck price target raised to $180 from $155 at Wolfe Research

TIPRANKS
·
Aug 25

Merck (MRK) Stock May Be 35% Undervalued After Cancer Vaccine Data

Simply Wall St.
·
Aug 25

Freshpet (FRPT) Climbed, So What Is Drawing Attention Now?

Simply Wall St.
·
Aug 25

Revvity Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 25

Zoetis Files Form 3 for EVP, CFO and COO James Saccaro

Reuters
·
Aug 25

Moderna is Betting Big on Its Cancer Vaccine. This is What Wall Street Wants to See.

Dow Jones
·
Aug 24

Barclays Raises Moderna PT on 'transformative' Melanoma Vaccine Potential

Reuters
·
Aug 24

BUZZ-US Stocks Weekly: Rate Rattle

Reuters
·
Aug 24

Celltrion Seeks Korean Approval for Keytruda Biosimilar CT-P51 After Positive Trial

TIPRANKS
·
Aug 24

AMD Stock Joins Cash Flow Picks Trading Below Fair Value

Simply Wall St.
·
Aug 24

Hype for Moderna's Cancer Vaccine is Running Ahead of the Math - Heard on the Street

Dow Jones
·
Aug 23

Moderna (MRNA) Posts First Late Stage mRNA Cancer Vaccine Win In Melanoma

Simply Wall St.
·
Aug 23

Merck & Company Soars on Breakthrough Cancer Vaccine Hopes

TIPRANKS
·
Aug 22

Broadcom Stock Headlines 3 Cash Flow Picks Trading Below Fair Value

Simply Wall St.
·
Aug 22

Moderna, ADI, Merck, EPR, TJX: Trending With Analysts

TIPRANKS
·
Aug 22